First Time Loading...
A

Allmed Medical Products Co Ltd
SZSE:002950

Watchlist Manager
Allmed Medical Products Co Ltd
SZSE:002950
Watchlist
Price: 8.23 CNY 3.65% Market Closed
Updated: May 5, 2024

Allmed Medical Products Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allmed Medical Products Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
1066
S
600529
603658
300888
300832

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
Allmed Medical Products Co Ltd
SZSE:002950
Cash from Financing Activities
-¥236.4m
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Cash from Financing Activities
-¥2.3B
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Cash from Financing Activities
¥1.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Cash from Financing Activities
-¥334.9m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Cash from Financing Activities
¥1.1B
CAGR 3-Years
N/A
CAGR 5-Years
39%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Cash from Financing Activities
-¥568.6m
CAGR 3-Years
N/A
CAGR 5-Years
-41%
CAGR 10-Years
N/A

See Also

What is Allmed Medical Products Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-236.4m CNY

Based on the financial report for Dec 31, 2022, Allmed Medical Products Co Ltd's Cash from Financing Activities amounts to -236.4m CNY.

What is Allmed Medical Products Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-40%

Over the last year, the Cash from Financing Activities growth was 57%. The average annual Cash from Financing Activities growth rates for Allmed Medical Products Co Ltd have been -40% over the past three years .